Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.52
-0.26 (-2.96%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ocular Therapeutix Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 427.22 | 195.81 | 102.3 | 164.16 | 228.06 | 54.44 | Upgrade
|
| Cash & Short-Term Investments | 427.22 | 195.81 | 102.3 | 164.16 | 228.06 | 54.44 | Upgrade
|
| Cash Growth | 286.45% | 91.40% | -37.68% | -28.02% | 318.94% | 0.69% | Upgrade
|
| Accounts Receivable | 30.24 | 26.18 | 21.33 | 21.14 | 12.25 | 2.55 | Upgrade
|
| Receivables | 30.24 | 26.18 | 21.33 | 21.14 | 12.25 | 2.55 | Upgrade
|
| Inventory | 2.41 | 2.31 | 1.97 | 1.25 | 1.2 | 0.95 | Upgrade
|
| Prepaid Expenses | 13.15 | 7.79 | 4.03 | 4.75 | 3.39 | 2.23 | Upgrade
|
| Restricted Cash | - | 0.15 | - | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | 1.26 | - | Upgrade
|
| Total Current Assets | 473.01 | 232.24 | 129.63 | 191.3 | 246.16 | 60.17 | Upgrade
|
| Property, Plant & Equipment | 15.74 | 18.21 | 17.9 | 11.82 | 13.94 | 16.81 | Upgrade
|
| Other Long-Term Assets | 1.61 | 1.61 | 1.76 | 1.76 | 1.76 | 1.76 | Upgrade
|
| Total Assets | 490.37 | 252.06 | 149.29 | 204.89 | 261.86 | 78.74 | Upgrade
|
| Accounts Payable | 4 | 4.39 | 5.12 | 4.59 | 2.71 | 3.27 | Upgrade
|
| Accrued Expenses | 30.45 | 28.67 | 24.1 | 20.12 | 14.31 | 7.64 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 8.29 | - | Upgrade
|
| Current Portion of Leases | 1.72 | 1.59 | 1.6 | 1.62 | 1.36 | 1.13 | Upgrade
|
| Current Unearned Revenue | 0.19 | 0.26 | 0.58 | - | - | - | Upgrade
|
| Total Current Liabilities | 36.36 | 34.9 | 31.4 | 26.34 | 26.66 | 12.03 | Upgrade
|
| Long-Term Debt | 67.82 | 74.93 | 54.01 | 51.44 | 41.24 | 49.31 | Upgrade
|
| Long-Term Leases | 5.59 | 6.88 | 8.68 | 5.92 | 7.55 | 8.91 | Upgrade
|
| Long-Term Unearned Revenue | 14 | 14.14 | 13.39 | 13 | 12 | - | Upgrade
|
| Other Long-Term Liabilities | 14.58 | 30.1 | 6.44 | 20.19 | 98.31 | 12.12 | Upgrade
|
| Total Liabilities | 138.35 | 160.93 | 113.91 | 116.89 | 185.77 | 82.37 | Upgrade
|
| Common Stock | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,195 | 788.7 | 652.21 | 633.8 | 615.34 | 379.98 | Upgrade
|
| Retained Earnings | -842.7 | -697.58 | -616.84 | -545.8 | -539.25 | -383.62 | Upgrade
|
| Total Common Equity | 352.02 | 91.13 | 35.38 | 88 | 76.1 | -3.63 | Upgrade
|
| Shareholders' Equity | 352.02 | 91.13 | 35.38 | 88 | 76.1 | -3.63 | Upgrade
|
| Total Liabilities & Equity | 490.37 | 252.06 | 149.29 | 204.89 | 261.86 | 78.74 | Upgrade
|
| Total Debt | 75.12 | 83.39 | 64.28 | 58.98 | 58.44 | 59.34 | Upgrade
|
| Net Cash (Debt) | 352.1 | 112.42 | 38.02 | 105.18 | 169.62 | -4.91 | Upgrade
|
| Net Cash Growth | 1178.86% | 195.70% | -63.86% | -37.99% | - | - | Upgrade
|
| Net Cash Per Share | 2.56 | 1.31 | 0.46 | 1.28 | 2.79 | -0.11 | Upgrade
|
| Filing Date Shares Outstanding | 157.22 | 148.63 | 77.51 | 76.75 | 76.07 | 52.58 | Upgrade
|
| Total Common Shares Outstanding | 156.65 | 114.96 | 77.2 | 76.73 | 76 | 50.33 | Upgrade
|
| Working Capital | 436.65 | 197.34 | 98.23 | 164.96 | 219.5 | 48.14 | Upgrade
|
| Book Value Per Share | 2.25 | 0.79 | 0.46 | 1.15 | 1.00 | -0.07 | Upgrade
|
| Tangible Book Value | 352.02 | 91.13 | 35.38 | 88 | 76.1 | -3.63 | Upgrade
|
| Tangible Book Value Per Share | 2.25 | 0.79 | 0.46 | 1.15 | 1.00 | -0.07 | Upgrade
|
| Machinery | - | 16.78 | 13.75 | 12.28 | 11.47 | 10.64 | Upgrade
|
| Construction In Progress | - | 0.28 | 4.07 | 0.58 | 0.12 | 0.24 | Upgrade
|
| Leasehold Improvements | - | 14.7 | 9.07 | 9.07 | 9.07 | 9.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.